Biomedicines · 2021 · 40 citations · 98 references
EngineeringBioengineeringBiotechnologyBiomaterialsRegenerative MedicineTissue EngineeringCell-scaffold InteractionsRegenerative ScaffoldsScaffold DesignStem Cell BioengineeringTissue Engineering ScaffoldsTissue Engineering With Stem CellsAdipose Stem CellsAdipose-derived Mesenchymal Stem CellsAngiogenic ResponseAutologous Stem Cell TherapyDiabetic Wound HealingDiabetic Wound RepairNanoparticlesTissue Healing Response
Non-healing diabetic foot ulcers (DFUs) can lead to leg amputation in diabetic patients. Autologous stem cell therapy holds some potential to solve this problem; however, diabetic stem cells are relatively dysfunctional and restrictive in their wound healing abilities. This study sought to explore if a novel collagen-chondroitin sulfate (coll-CS) scaffold, functionalized with polyplex nanoparticles carrying the gene encoding for stromal-derived factor-1 alpha (SDF-1α gene-activated scaffold), can enhance the regenerative functionality of human diabetic adipose-derived stem cells (ADSCs). We assessed the impact of the gene-activated scaffold on diabetic ADSCs by comparing their response against healthy ADSCs cultured on a gene-free scaffold over two weeks. Overall, we found that the gene-activated scaffold could restore the pro-angiogenic regenerative response in the human diabetic ADSCs similar to the healthy ADSCs on the gene-free scaffold. Gene and protein expression analysis revealed that the gene-activated scaffold induced the overexpression of SDF-1α in diabetic ADSCs and engaged the receptor CXCR7, causing downstream β-arrestin signaling, as effectively as the transfected healthy ADSCs. The transfected diabetic ADSCs also exhibited pro-wound healing features characterized by active matrix remodeling of the provisional fibronectin matrix and basement membrane protein collagen IV. The gene-activated scaffold also induced a controlled pro-healing response in the healthy ADSCs by disabling early developmental factors signaling while promoting the expression of tissue remodeling components. Conclusively, we show that the SDF-1α gene-activated scaffold can overcome the deficiencies associated with diabetic ADSCs, paving the way for autologous stem cell therapies combined with novel biomaterials to treat DFUs.
98
Vascular endothelial growth factor (VEGF) and its receptors
Gera Neufeld, Tzafra Cohen, Stela Gengrinovitch et al. · The FASEB Journal · 1999 · 3.5K citations
Medicine, Cell Biology, Oncology +17
Biomaterials & scaffolds for tissue engineering
Fergal J. O’Brien · Materials Today · 2011 · 3.4K citations · Full text
Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering
Lie Ma, Changyou Gao, Zhengwei Mao et al. · Biomaterials · 2003 · 1.1K citations